CTOs on the Move

Cardiovascular Systems, Inc.

www.csi360.com

 
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.csi360.com
  • 1225 Old Highway 8 NW
    Saint Paul, MN USA 55112
  • Phone: 651.259.1600

Executives

Name Title Contact Details
Andrew O'Brien
Vice President Information Technology Profile
Urooj Ahmed
Director, IT Profile
Amy Browne
Vice President of Information Technology Profile

Similar Companies

Taut

Taut, Inc. is a Geneva, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthline Systems Inc

Healthline Systems Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmed

Pharmed is a Westlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EG GILERO

EG GILERO is the merger of trusted companies in the medical device industry whose roots go back decades. GILERO Biomedical, Medacys, InField Medical and the medical businesses of eNNOVEA and ValTech Holdings have been brought together by EGI, Inc. to create one vertically integrated resource for the medical device industry.    EG GILERO is your single-source, trusted partner for design, development and manufacturing within the medical devices, drug delivery, and primary pharmaceutical packaging markets. With operations in the United States and Asia, EG GILERO is strategically positioned to provide the value added services our clients require in a competitive, ever-changing global marketplace.    Together, we will accelerate your device timelines from concept to commercialization.

Lensar

LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest laser footprint and thoughtful ergonomic design that accommodates most operating rooms. The LENSAR Laser System has been cleared by FDA for anterior capsulotomy, lens fragmentation, and corneal and arcuate incisions. For other indications it is an investigational device limited by U.S. law to investigational use only